Pay-As-You-Go Effects for S. 3525, as Introduced on September 12, 2012
Cost Estimates Search
- Cost Estimate
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187,the Food and Drug Administration Safety and Innovation Act, with Further Amendments Adopted by the Senate through May 24, 2012
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187, the Food and Drug Administration Safety and Innovation Act
- Cost Estimate
Estimate of the direct spending and revenue effects of the bill as cleared by the Congress on October 3, 2008, and signed by the President on October 16, 2008
- Cost Estimate
Estimate of the direct spending and revenue effects of the bill as cleared by the Congress on September 10, 2008, and signed by the President on September 24, 2008
- Cost Estimate
Cost estimate for the bill as transmitted to the President on October 6, 2008
- Cost Estimate
Cost estimate for the bill as cleared by the Congress on July 10, 2008, and signed by the President on July 17, 2008
- Cost Estimate
Direct spending and revenues effects estimate for the bill as cleared by the Congress on July 31, 2008
- Cost Estimate
Direct spending and revenues effects estimate for the bill as cleared by the Congress on July 24, 2008, and signed by the President on July 29, 2008
- Cost Estimate
Cost estimate for the bill as introduced on July 22, 2008.